Most lifestyle diseases are systemic in nature, primarily caused by poor diet and unhealthy lifestyle choices. These diseases ...

Kidney cancer is one of the less frequently heard-about cancers, but its worldwide incidence is increasing. The lesser-known ...

Insulin resistance is now found in both Type 2 diabetes and Alzheimer's brains * Impaired glucose metabolism may drive early ...

Secondary forms of metabolic dysfunction-associated steatotic liver disease (MASLD) have different pathogeneses, ...

Thus, it is likely that many of the growth and atherosclerotic effects that have been attributed to insulin are mediated through an IGF-1 receptor either directly by IGF-1 or indirectly by high ...

The global surge in diabetes cases is a key factor propelling the artificial pancreas device market, as a larger patient base fuels the need for effe ...

Muscles act like brain meds, boosting memory and mood better than supplements. Here's why strength training is key to ...

We’re on track to develop the first-ever FDA-approved drug for longevity – for any species,” Celine Halioua told The Post.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

The discovery of GFB-111 demonstrates that a designed synthetic molecule can bind to a growth factor, and disrupt its biological activity by preventing it from binding to its receptor. This is a ...

The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...